| Trade Names: | |
| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | TU7HW0W0QT |
| InChI Key | NGSFWBMYFKHRBD-UHFFFAOYSA-M |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C3H5NaO3 |
| Molecular Weight | 112.06 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Severe Dengue | 3 | D019595 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Pancreatitis | 3 | D010195 | ClinicalTrials |
| Subarachnoid Hemorrhage | 3 | D013345 | ClinicalTrials |
| Burns | 3 | D002056 | ClinicalTrials |
| Shock | 3 | D012769 | ClinicalTrials |
| Pancreatitis | 3 | D010195 | ClinicalTrials |
| Hypovolemia | 3 | D020896 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Shock, Septic | 2 | D012772 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Scleroderma, Systemic | 2 | D012595 | ClinicalTrials |
| Reperfusion Injury | 2 | D015427 | ClinicalTrials |
| Postoperative Nausea and Vomiting | 2 | D020250 | ClinicalTrials |
| Intestinal Diseases | 2 | D007410 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Cataract | 2 | D002386 | ClinicalTrials |
| Wounds and Injuries | 2 | D014947 | ClinicalTrials |
| Hypotension | 1 | D007022 | ClinicalTrials |
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
| Hearing Loss | 1 | D034381 | ClinicalTrials |
| Virus Diseases | 1 | D014777 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 75228 |
| ChEMBL | CHEMBL1357 |
| EPA CompTox | DTXSID6052829 |
| FDA SRS | TU7HW0W0QT |
| PubChem | 23666456 |
| SureChEMBL | SCHEMBL4360 |